BeautyHealth Q4 net sales $83.5M; adjusted EBITDA $9M, exceeds guidance high end

SkinHealth Systems Inc.

Q4 net sales $83.5M, full year $334.3M; adjusted EBITDA $9.0M (10.8% margin), exceeding guidance.
Consumables net sales rose to $56.7M in Q4; delivery systems sold 1,087 (down from 1,551 YoY).
Active install base grew to 34,735 from 31,446 a year ago, up 10.5%.
Gross margin expanded to 62.7% in Q4 vs. 47.2% in Q4 2023; full year margin 54.5% vs. 39.0%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.